Elan Announces Filing of Annual Report on Form 20-F for Year Ended December 31, 2012

DUBLIN--()--

Elan Corporation, plc (NYSE: ELN) today announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2012. The Form 20-F is available on Elan's website at http://www.elan.com. Elan will provide to all holders of Elan securities, upon request and free of charge, a hard copy of our complete audited financial statements included in our Form 20-F.

About Elan Corporation, plc

Elan Corporation, plc is a biotechnology company, headquartered in Ireland, committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan shares trade on the New York and Irish Stock Exchanges. For additional information about the Elan, please visit http://www.elan.com.

Elan Corporation
Investor Relations:
Chris Burns, 800-252-3526
David Marshall, 353-1-709-4444
or
Media Relations:
Emer Reynolds, + 353-1-709-4022
Jonathan Birt, +44-751-559-7858

Short Name: Elan Corporation PLC
Category Code: MSC
Sequence Number: 363122
Time of Receipt (offset from UTC): 20130212T200002+0000

Contacts

Elan Corporation PLC

Sharing

Contacts

Elan Corporation PLC